nodes	percent_of_prediction	percent_of_DWPC	metapath
Carbimazole—TPO—Hematopoietic Stem Cell Differentiation—MXI1—peripheral nervous system neoplasm	0.0503	0.288	CbGpPWpGaD
Carbimazole—TPO—Differentiation Pathway—ALK—peripheral nervous system neoplasm	0.0348	0.199	CbGpPWpGaD
Carbimazole—TPO—Amine-derived hormones—TH—peripheral nervous system neoplasm	0.0276	0.158	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism of steroid hormones and vitamin D—HSD17B12—peripheral nervous system neoplasm	0.0136	0.0777	CbGpPWpGaD
Carbimazole—TPO—Differentiation Pathway—HGF—peripheral nervous system neoplasm	0.00892	0.0511	CbGpPWpGaD
Carbimazole—CYP19A1—FSH signaling pathway—BDNF—peripheral nervous system neoplasm	0.00451	0.0259	CbGpPWpGaD
Carbimazole—TPO—Amino acid and derivative metabolism—TH—peripheral nervous system neoplasm	0.00385	0.022	CbGpPWpGaD
Carbimazole—CYP19A1—Integrated Breast Cancer Pathway—BARD1—peripheral nervous system neoplasm	0.00341	0.0196	CbGpPWpGaD
Carbimazole—TPO—Metabolism—PPIP5K2—peripheral nervous system neoplasm	0.00301	0.0172	CbGpPWpGaD
Carbimazole—Ageusia—Epirubicin—peripheral nervous system neoplasm	0.00263	0.00318	CcSEcCtD
Carbimazole—Ill-defined disorder—Topotecan—peripheral nervous system neoplasm	0.00263	0.00318	CcSEcCtD
Carbimazole—Ill-defined disorder—Tretinoin—peripheral nervous system neoplasm	0.0026	0.00316	CcSEcCtD
Carbimazole—Ill-defined disorder—Isotretinoin—peripheral nervous system neoplasm	0.0026	0.00316	CcSEcCtD
Carbimazole—Angioedema—Topotecan—peripheral nervous system neoplasm	0.00259	0.00313	CcSEcCtD
Carbimazole—Stomatitis—Vincristine—peripheral nervous system neoplasm	0.00256	0.0031	CcSEcCtD
Carbimazole—Malaise—Topotecan—peripheral nervous system neoplasm	0.00255	0.00309	CcSEcCtD
Carbimazole—Agranulocytosis—Alitretinoin—peripheral nervous system neoplasm	0.00254	0.00308	CcSEcCtD
Carbimazole—Leukopenia—Topotecan—peripheral nervous system neoplasm	0.00253	0.00307	CcSEcCtD
Carbimazole—Malaise—Isotretinoin—peripheral nervous system neoplasm	0.00253	0.00307	CcSEcCtD
Carbimazole—Malaise—Tretinoin—peripheral nervous system neoplasm	0.00253	0.00307	CcSEcCtD
Carbimazole—Leukopenia—Melphalan—peripheral nervous system neoplasm	0.00248	0.003	CcSEcCtD
Carbimazole—Pancytopenia—Cisplatin—peripheral nervous system neoplasm	0.00247	0.00299	CcSEcCtD
Carbimazole—Haemoglobin—Alitretinoin—peripheral nervous system neoplasm	0.00246	0.00298	CcSEcCtD
Carbimazole—Hepatitis—Alitretinoin—peripheral nervous system neoplasm	0.00244	0.00296	CcSEcCtD
Carbimazole—Haemorrhage—Alitretinoin—peripheral nervous system neoplasm	0.00244	0.00296	CcSEcCtD
Carbimazole—Ageusia—Doxorubicin—peripheral nervous system neoplasm	0.00243	0.00295	CcSEcCtD
Carbimazole—Jaundice cholestatic—Epirubicin—peripheral nervous system neoplasm	0.00242	0.00294	CcSEcCtD
Carbimazole—Arthralgia—Topotecan—peripheral nervous system neoplasm	0.00241	0.00292	CcSEcCtD
Carbimazole—Myalgia—Topotecan—peripheral nervous system neoplasm	0.00241	0.00292	CcSEcCtD
Carbimazole—Unspecified disorder of skin and subcutaneous tissue—Topotecan—peripheral nervous system neoplasm	0.00239	0.0029	CcSEcCtD
Carbimazole—Myalgia—Isotretinoin—peripheral nervous system neoplasm	0.00239	0.0029	CcSEcCtD
Carbimazole—Arthralgia—Tretinoin—peripheral nervous system neoplasm	0.00239	0.0029	CcSEcCtD
Carbimazole—Arthralgia—Isotretinoin—peripheral nervous system neoplasm	0.00239	0.0029	CcSEcCtD
Carbimazole—Myalgia—Tretinoin—peripheral nervous system neoplasm	0.00239	0.0029	CcSEcCtD
Carbimazole—Discomfort—Topotecan—peripheral nervous system neoplasm	0.00238	0.00288	CcSEcCtD
Carbimazole—Unspecified disorder of skin and subcutaneous tissue—Isotretinoin—peripheral nervous system neoplasm	0.00237	0.00288	CcSEcCtD
Carbimazole—Unspecified disorder of skin and subcutaneous tissue—Tretinoin—peripheral nervous system neoplasm	0.00237	0.00288	CcSEcCtD
Carbimazole—Discomfort—Isotretinoin—peripheral nervous system neoplasm	0.00236	0.00286	CcSEcCtD
Carbimazole—Discomfort—Tretinoin—peripheral nervous system neoplasm	0.00236	0.00286	CcSEcCtD
Carbimazole—Myalgia—Melphalan—peripheral nervous system neoplasm	0.00236	0.00286	CcSEcCtD
Carbimazole—Unspecified disorder of skin and subcutaneous tissue—Melphalan—peripheral nervous system neoplasm	0.00234	0.00284	CcSEcCtD
Carbimazole—Alopecia—Dactinomycin—peripheral nervous system neoplasm	0.00233	0.00282	CcSEcCtD
Carbimazole—Infection—Topotecan—peripheral nervous system neoplasm	0.00229	0.00278	CcSEcCtD
Carbimazole—Infection—Isotretinoin—peripheral nervous system neoplasm	0.00228	0.00276	CcSEcCtD
Carbimazole—Infection—Tretinoin—peripheral nervous system neoplasm	0.00228	0.00276	CcSEcCtD
Carbimazole—Nervous system disorder—Topotecan—peripheral nervous system neoplasm	0.00227	0.00274	CcSEcCtD
Carbimazole—Pancytopenia—Etoposide—peripheral nervous system neoplasm	0.00226	0.00274	CcSEcCtD
Carbimazole—Thrombocytopenia—Topotecan—peripheral nervous system neoplasm	0.00226	0.00274	CcSEcCtD
Carbimazole—Stomatitis—Cisplatin—peripheral nervous system neoplasm	0.00226	0.00274	CcSEcCtD
Carbimazole—Nervous system disorder—Tretinoin—peripheral nervous system neoplasm	0.00225	0.00272	CcSEcCtD
Carbimazole—Nervous system disorder—Isotretinoin—peripheral nervous system neoplasm	0.00225	0.00272	CcSEcCtD
Carbimazole—Infection—Melphalan—peripheral nervous system neoplasm	0.00225	0.00272	CcSEcCtD
Carbimazole—Skin disorder—Topotecan—peripheral nervous system neoplasm	0.00224	0.00272	CcSEcCtD
Carbimazole—Thrombocytopenia—Isotretinoin—peripheral nervous system neoplasm	0.00224	0.00272	CcSEcCtD
Carbimazole—Thrombocytopenia—Tretinoin—peripheral nervous system neoplasm	0.00224	0.00272	CcSEcCtD
Carbimazole—Jaundice cholestatic—Doxorubicin—peripheral nervous system neoplasm	0.00224	0.00272	CcSEcCtD
Carbimazole—Neutropenia—Etoposide—peripheral nervous system neoplasm	0.00223	0.0027	CcSEcCtD
Carbimazole—Skin disorder—Isotretinoin—peripheral nervous system neoplasm	0.00223	0.0027	CcSEcCtD
Carbimazole—Skin disorder—Tretinoin—peripheral nervous system neoplasm	0.00223	0.0027	CcSEcCtD
Carbimazole—Angiopathy—Alitretinoin—peripheral nervous system neoplasm	0.00222	0.00269	CcSEcCtD
Carbimazole—Thrombocytopenia—Melphalan—peripheral nervous system neoplasm	0.00221	0.00268	CcSEcCtD
Carbimazole—Skin disorder—Melphalan—peripheral nervous system neoplasm	0.0022	0.00266	CcSEcCtD
Carbimazole—Alopecia—Alitretinoin—peripheral nervous system neoplasm	0.00216	0.00262	CcSEcCtD
Carbimazole—Angiopathy—Vincristine—peripheral nervous system neoplasm	0.00214	0.00259	CcSEcCtD
Carbimazole—Hepatocellular injury—Epirubicin—peripheral nervous system neoplasm	0.00213	0.00258	CcSEcCtD
Carbimazole—Ill-defined disorder—Dactinomycin—peripheral nervous system neoplasm	0.00213	0.00258	CcSEcCtD
Carbimazole—CYP19A1—Integrated Breast Cancer Pathway—NF1—peripheral nervous system neoplasm	0.00211	0.0121	CbGpPWpGaD
Carbimazole—Musculoskeletal discomfort—Topotecan—peripheral nervous system neoplasm	0.0021	0.00255	CcSEcCtD
Carbimazole—Musculoskeletal discomfort—Isotretinoin—peripheral nervous system neoplasm	0.00209	0.00253	CcSEcCtD
Carbimazole—Musculoskeletal discomfort—Tretinoin—peripheral nervous system neoplasm	0.00209	0.00253	CcSEcCtD
Carbimazole—Alopecia—Vincristine—peripheral nervous system neoplasm	0.00208	0.00252	CcSEcCtD
Carbimazole—Jaundice—Etoposide—peripheral nervous system neoplasm	0.00207	0.00251	CcSEcCtD
Carbimazole—Stomatitis—Etoposide—peripheral nervous system neoplasm	0.00207	0.00251	CcSEcCtD
Carbimazole—Malaise—Dactinomycin—peripheral nervous system neoplasm	0.00207	0.00251	CcSEcCtD
Carbimazole—Musculoskeletal discomfort—Melphalan—peripheral nervous system neoplasm	0.00206	0.0025	CcSEcCtD
Carbimazole—Leukopenia—Dactinomycin—peripheral nervous system neoplasm	0.00205	0.00249	CcSEcCtD
Carbimazole—TPO—Metabolism—HSD17B12—peripheral nervous system neoplasm	0.00203	0.0116	CbGpPWpGaD
Carbimazole—Aplastic anaemia—Epirubicin—peripheral nervous system neoplasm	0.002	0.00242	CcSEcCtD
Carbimazole—Agranulocytosis—Etoposide—peripheral nervous system neoplasm	0.00198	0.0024	CcSEcCtD
Carbimazole—Ill-defined disorder—Alitretinoin—peripheral nervous system neoplasm	0.00197	0.00239	CcSEcCtD
Carbimazole—Hepatocellular injury—Doxorubicin—peripheral nervous system neoplasm	0.00197	0.00239	CcSEcCtD
Carbimazole—Myalgia—Dactinomycin—peripheral nervous system neoplasm	0.00195	0.00237	CcSEcCtD
Carbimazole—Discomfort—Dactinomycin—peripheral nervous system neoplasm	0.00193	0.00234	CcSEcCtD
Carbimazole—Mouth ulceration—Epirubicin—peripheral nervous system neoplasm	0.00193	0.00233	CcSEcCtD
Carbimazole—Malaise—Alitretinoin—peripheral nervous system neoplasm	0.00192	0.00232	CcSEcCtD
Carbimazole—Feeling abnormal—Topotecan—peripheral nervous system neoplasm	0.0019	0.00231	CcSEcCtD
Carbimazole—Feeling abnormal—Isotretinoin—peripheral nervous system neoplasm	0.00189	0.00229	CcSEcCtD
Carbimazole—Feeling abnormal—Tretinoin—peripheral nervous system neoplasm	0.00189	0.00229	CcSEcCtD
Carbimazole—Infection—Dactinomycin—peripheral nervous system neoplasm	0.00186	0.00225	CcSEcCtD
Carbimazole—Aplastic anaemia—Doxorubicin—peripheral nervous system neoplasm	0.00185	0.00224	CcSEcCtD
Carbimazole—Alopecia—Cisplatin—peripheral nervous system neoplasm	0.00184	0.00223	CcSEcCtD
Carbimazole—Leukopenia—Vincristine—peripheral nervous system neoplasm	0.00184	0.00222	CcSEcCtD
Carbimazole—Urticaria—Topotecan—peripheral nervous system neoplasm	0.00183	0.00222	CcSEcCtD
Carbimazole—Thrombocytopenia—Dactinomycin—peripheral nervous system neoplasm	0.00183	0.00222	CcSEcCtD
Carbimazole—Body temperature increased—Topotecan—peripheral nervous system neoplasm	0.00183	0.00221	CcSEcCtD
Carbimazole—Urticaria—Tretinoin—peripheral nervous system neoplasm	0.00182	0.00221	CcSEcCtD
Carbimazole—Urticaria—Isotretinoin—peripheral nervous system neoplasm	0.00182	0.00221	CcSEcCtD
Carbimazole—Arthralgia—Alitretinoin—peripheral nervous system neoplasm	0.00181	0.00219	CcSEcCtD
Carbimazole—Myalgia—Alitretinoin—peripheral nervous system neoplasm	0.00181	0.00219	CcSEcCtD
Carbimazole—Body temperature increased—Tretinoin—peripheral nervous system neoplasm	0.00181	0.00219	CcSEcCtD
Carbimazole—Body temperature increased—Isotretinoin—peripheral nervous system neoplasm	0.00181	0.00219	CcSEcCtD
Carbimazole—Unspecified disorder of skin and subcutaneous tissue—Alitretinoin—peripheral nervous system neoplasm	0.0018	0.00218	CcSEcCtD
Carbimazole—Urticaria—Melphalan—peripheral nervous system neoplasm	0.0018	0.00218	CcSEcCtD
Carbimazole—Discomfort—Alitretinoin—peripheral nervous system neoplasm	0.00179	0.00217	CcSEcCtD
Carbimazole—Mouth ulceration—Doxorubicin—peripheral nervous system neoplasm	0.00178	0.00216	CcSEcCtD
Carbimazole—Myalgia—Vincristine—peripheral nervous system neoplasm	0.00175	0.00211	CcSEcCtD
Carbimazole—Angiopathy—Etoposide—peripheral nervous system neoplasm	0.00173	0.0021	CcSEcCtD
Carbimazole—Infection—Alitretinoin—peripheral nervous system neoplasm	0.00173	0.00209	CcSEcCtD
Carbimazole—Musculoskeletal discomfort—Dactinomycin—peripheral nervous system neoplasm	0.00171	0.00207	CcSEcCtD
Carbimazole—Nervous system disorder—Alitretinoin—peripheral nervous system neoplasm	0.0017	0.00206	CcSEcCtD
Carbimazole—Hypersensitivity—Topotecan—peripheral nervous system neoplasm	0.0017	0.00206	CcSEcCtD
Carbimazole—Thrombocytopenia—Alitretinoin—peripheral nervous system neoplasm	0.0017	0.00206	CcSEcCtD
Carbimazole—Hypersensitivity—Isotretinoin—peripheral nervous system neoplasm	0.00169	0.00205	CcSEcCtD
Carbimazole—Hypersensitivity—Tretinoin—peripheral nervous system neoplasm	0.00169	0.00205	CcSEcCtD
Carbimazole—Skin disorder—Alitretinoin—peripheral nervous system neoplasm	0.00169	0.00204	CcSEcCtD
Carbimazole—Alopecia—Etoposide—peripheral nervous system neoplasm	0.00169	0.00204	CcSEcCtD
Carbimazole—Ill-defined disorder—Cisplatin—peripheral nervous system neoplasm	0.00168	0.00204	CcSEcCtD
Carbimazole—Hypersensitivity—Melphalan—peripheral nervous system neoplasm	0.00167	0.00202	CcSEcCtD
Carbimazole—Infection—Vincristine—peripheral nervous system neoplasm	0.00166	0.00201	CcSEcCtD
Carbimazole—Nervous system disorder—Vincristine—peripheral nervous system neoplasm	0.00164	0.00199	CcSEcCtD
Carbimazole—Thrombocytopenia—Vincristine—peripheral nervous system neoplasm	0.00164	0.00198	CcSEcCtD
Carbimazole—Malaise—Cisplatin—peripheral nervous system neoplasm	0.00163	0.00198	CcSEcCtD
Carbimazole—Pruritus—Topotecan—peripheral nervous system neoplasm	0.00163	0.00198	CcSEcCtD
Carbimazole—Leukopenia—Cisplatin—peripheral nervous system neoplasm	0.00162	0.00197	CcSEcCtD
Carbimazole—Pruritus—Isotretinoin—peripheral nervous system neoplasm	0.00162	0.00196	CcSEcCtD
Carbimazole—Pruritus—Tretinoin—peripheral nervous system neoplasm	0.00162	0.00196	CcSEcCtD
Carbimazole—Pruritus—Melphalan—peripheral nervous system neoplasm	0.0016	0.00194	CcSEcCtD
Carbimazole—Musculoskeletal discomfort—Alitretinoin—peripheral nervous system neoplasm	0.00158	0.00192	CcSEcCtD
Carbimazole—Myalgia—Cisplatin—peripheral nervous system neoplasm	0.00154	0.00187	CcSEcCtD
Carbimazole—Feeling abnormal—Dactinomycin—peripheral nervous system neoplasm	0.00154	0.00187	CcSEcCtD
Carbimazole—Ill-defined disorder—Etoposide—peripheral nervous system neoplasm	0.00154	0.00187	CcSEcCtD
Carbimazole—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—peripheral nervous system neoplasm	0.00153	0.00186	CcSEcCtD
Carbimazole—Discomfort—Cisplatin—peripheral nervous system neoplasm	0.00152	0.00185	CcSEcCtD
Carbimazole—CYP19A1—Integrated Breast Cancer Pathway—AURKA—peripheral nervous system neoplasm	0.00152	0.00874	CbGpPWpGaD
Carbimazole—Musculoskeletal discomfort—Vincristine—peripheral nervous system neoplasm	0.00152	0.00185	CcSEcCtD
Carbimazole—Malaise—Etoposide—peripheral nervous system neoplasm	0.0015	0.00181	CcSEcCtD
Carbimazole—Leukopenia—Etoposide—peripheral nervous system neoplasm	0.00149	0.0018	CcSEcCtD
Carbimazole—Body temperature increased—Dactinomycin—peripheral nervous system neoplasm	0.00148	0.00179	CcSEcCtD
Carbimazole—Infection—Cisplatin—peripheral nervous system neoplasm	0.00147	0.00178	CcSEcCtD
Carbimazole—TPO—Metabolism—GNS—peripheral nervous system neoplasm	0.00147	0.00841	CbGpPWpGaD
Carbimazole—Rash—Topotecan—peripheral nervous system neoplasm	0.00146	0.00176	CcSEcCtD
Carbimazole—Dermatitis—Topotecan—peripheral nervous system neoplasm	0.00146	0.00176	CcSEcCtD
Carbimazole—Nervous system disorder—Cisplatin—peripheral nervous system neoplasm	0.00145	0.00176	CcSEcCtD
Carbimazole—Thrombocytopenia—Cisplatin—peripheral nervous system neoplasm	0.00145	0.00175	CcSEcCtD
Carbimazole—Headache—Topotecan—peripheral nervous system neoplasm	0.00145	0.00175	CcSEcCtD
Carbimazole—Rash—Isotretinoin—peripheral nervous system neoplasm	0.00144	0.00175	CcSEcCtD
Carbimazole—Rash—Tretinoin—peripheral nervous system neoplasm	0.00144	0.00175	CcSEcCtD
Carbimazole—Dermatitis—Tretinoin—peripheral nervous system neoplasm	0.00144	0.00175	CcSEcCtD
Carbimazole—Dermatitis—Isotretinoin—peripheral nervous system neoplasm	0.00144	0.00175	CcSEcCtD
Carbimazole—Skin disorder—Cisplatin—peripheral nervous system neoplasm	0.00144	0.00174	CcSEcCtD
Carbimazole—Headache—Isotretinoin—peripheral nervous system neoplasm	0.00144	0.00174	CcSEcCtD
Carbimazole—Headache—Tretinoin—peripheral nervous system neoplasm	0.00144	0.00174	CcSEcCtD
Carbimazole—Feeling abnormal—Alitretinoin—peripheral nervous system neoplasm	0.00143	0.00173	CcSEcCtD
Carbimazole—Liver function test abnormal—Epirubicin—peripheral nervous system neoplasm	0.00143	0.00173	CcSEcCtD
Carbimazole—Rash—Melphalan—peripheral nervous system neoplasm	0.00143	0.00173	CcSEcCtD
Carbimazole—Dermatitis—Melphalan—peripheral nervous system neoplasm	0.00142	0.00173	CcSEcCtD
Carbimazole—TPO—Metabolism—NME1—peripheral nervous system neoplasm	0.00141	0.00806	CbGpPWpGaD
Carbimazole—Unspecified disorder of skin and subcutaneous tissue—Etoposide—peripheral nervous system neoplasm	0.0014	0.0017	CcSEcCtD
Carbimazole—Discomfort—Etoposide—peripheral nervous system neoplasm	0.0014	0.00169	CcSEcCtD
Carbimazole—CYP19A1—Metabolism of lipids and lipoproteins—HSD17B12—peripheral nervous system neoplasm	0.00139	0.00796	CbGpPWpGaD
Carbimazole—Hypersensitivity—Dactinomycin—peripheral nervous system neoplasm	0.00138	0.00167	CcSEcCtD
Carbimazole—Urticaria—Alitretinoin—peripheral nervous system neoplasm	0.00138	0.00167	CcSEcCtD
Carbimazole—Body temperature increased—Alitretinoin—peripheral nervous system neoplasm	0.00137	0.00166	CcSEcCtD
Carbimazole—Nausea—Topotecan—peripheral nervous system neoplasm	0.00137	0.00166	CcSEcCtD
Carbimazole—CYP19A1—Integrated Breast Cancer Pathway—CHEK2—peripheral nervous system neoplasm	0.00136	0.00781	CbGpPWpGaD
Carbimazole—Nausea—Tretinoin—peripheral nervous system neoplasm	0.00136	0.00165	CcSEcCtD
Carbimazole—Nausea—Isotretinoin—peripheral nervous system neoplasm	0.00136	0.00165	CcSEcCtD
Carbimazole—TPO—Metabolism—COX2—peripheral nervous system neoplasm	0.00135	0.00776	CbGpPWpGaD
Carbimazole—Musculoskeletal discomfort—Cisplatin—peripheral nervous system neoplasm	0.00135	0.00163	CcSEcCtD
Carbimazole—Infection—Etoposide—peripheral nervous system neoplasm	0.00135	0.00163	CcSEcCtD
Carbimazole—Nausea—Melphalan—peripheral nervous system neoplasm	0.00134	0.00163	CcSEcCtD
Carbimazole—Thrombocytopenia—Etoposide—peripheral nervous system neoplasm	0.00133	0.00161	CcSEcCtD
Carbimazole—Eosinophilia—Epirubicin—peripheral nervous system neoplasm	0.00132	0.0016	CcSEcCtD
Carbimazole—Body temperature increased—Vincristine—peripheral nervous system neoplasm	0.00132	0.0016	CcSEcCtD
Carbimazole—Liver function test abnormal—Doxorubicin—peripheral nervous system neoplasm	0.00132	0.0016	CcSEcCtD
Carbimazole—Skin disorder—Etoposide—peripheral nervous system neoplasm	0.00132	0.00159	CcSEcCtD
Carbimazole—Hypersensitivity—Alitretinoin—peripheral nervous system neoplasm	0.00128	0.00155	CcSEcCtD
Carbimazole—Pancytopenia—Epirubicin—peripheral nervous system neoplasm	0.00127	0.00154	CcSEcCtD
Carbimazole—Neutropenia—Epirubicin—peripheral nervous system neoplasm	0.00125	0.00151	CcSEcCtD
Carbimazole—Hypersensitivity—Vincristine—peripheral nervous system neoplasm	0.00123	0.00149	CcSEcCtD
Carbimazole—Pruritus—Alitretinoin—peripheral nervous system neoplasm	0.00123	0.00149	CcSEcCtD
Carbimazole—Eosinophilia—Doxorubicin—peripheral nervous system neoplasm	0.00122	0.00148	CcSEcCtD
Carbimazole—CYP19A1—FSH signaling pathway—AKT1—peripheral nervous system neoplasm	0.00122	0.00699	CbGpPWpGaD
Carbimazole—Feeling abnormal—Cisplatin—peripheral nervous system neoplasm	0.00122	0.00148	CcSEcCtD
Carbimazole—Rash—Dactinomycin—peripheral nervous system neoplasm	0.00118	0.00143	CcSEcCtD
Carbimazole—Pancytopenia—Doxorubicin—peripheral nervous system neoplasm	0.00117	0.00142	CcSEcCtD
Carbimazole—Body temperature increased—Cisplatin—peripheral nervous system neoplasm	0.00117	0.00142	CcSEcCtD
Carbimazole—Stomatitis—Epirubicin—peripheral nervous system neoplasm	0.00116	0.00141	CcSEcCtD
Carbimazole—Jaundice—Epirubicin—peripheral nervous system neoplasm	0.00116	0.00141	CcSEcCtD
Carbimazole—Neutropenia—Doxorubicin—peripheral nervous system neoplasm	0.00116	0.0014	CcSEcCtD
Carbimazole—Feeling abnormal—Etoposide—peripheral nervous system neoplasm	0.00112	0.00135	CcSEcCtD
Carbimazole—Nausea—Dactinomycin—peripheral nervous system neoplasm	0.00111	0.00135	CcSEcCtD
Carbimazole—Agranulocytosis—Epirubicin—peripheral nervous system neoplasm	0.00111	0.00135	CcSEcCtD
Carbimazole—Rash—Alitretinoin—peripheral nervous system neoplasm	0.00109	0.00133	CcSEcCtD
Carbimazole—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	0.00109	0.00133	CcSEcCtD
Carbimazole—Hypersensitivity—Cisplatin—peripheral nervous system neoplasm	0.00109	0.00132	CcSEcCtD
Carbimazole—Headache—Alitretinoin—peripheral nervous system neoplasm	0.00109	0.00132	CcSEcCtD
Carbimazole—Urticaria—Etoposide—peripheral nervous system neoplasm	0.00108	0.0013	CcSEcCtD
Carbimazole—Haemoglobin—Epirubicin—peripheral nervous system neoplasm	0.00107	0.0013	CcSEcCtD
Carbimazole—Jaundice—Doxorubicin—peripheral nervous system neoplasm	0.00107	0.0013	CcSEcCtD
Carbimazole—Stomatitis—Doxorubicin—peripheral nervous system neoplasm	0.00107	0.0013	CcSEcCtD
Carbimazole—Body temperature increased—Etoposide—peripheral nervous system neoplasm	0.00107	0.0013	CcSEcCtD
Carbimazole—Hepatitis—Epirubicin—peripheral nervous system neoplasm	0.00107	0.0013	CcSEcCtD
Carbimazole—Haemorrhage—Epirubicin—peripheral nervous system neoplasm	0.00107	0.0013	CcSEcCtD
Carbimazole—Rash—Vincristine—peripheral nervous system neoplasm	0.00106	0.00128	CcSEcCtD
Carbimazole—Dermatitis—Vincristine—peripheral nervous system neoplasm	0.00105	0.00128	CcSEcCtD
Carbimazole—Headache—Vincristine—peripheral nervous system neoplasm	0.00105	0.00127	CcSEcCtD
Carbimazole—Nausea—Alitretinoin—peripheral nervous system neoplasm	0.00103	0.00125	CcSEcCtD
Carbimazole—Agranulocytosis—Doxorubicin—peripheral nervous system neoplasm	0.00103	0.00125	CcSEcCtD
Carbimazole—Hypersensitivity—Etoposide—peripheral nervous system neoplasm	0.000999	0.00121	CcSEcCtD
Carbimazole—Haemoglobin—Doxorubicin—peripheral nervous system neoplasm	0.000995	0.0012	CcSEcCtD
Carbimazole—Nausea—Vincristine—peripheral nervous system neoplasm	0.000994	0.0012	CcSEcCtD
Carbimazole—Hepatitis—Doxorubicin—peripheral nervous system neoplasm	0.00099	0.0012	CcSEcCtD
Carbimazole—Haemorrhage—Doxorubicin—peripheral nervous system neoplasm	0.00099	0.0012	CcSEcCtD
Carbimazole—Angiopathy—Epirubicin—peripheral nervous system neoplasm	0.00097	0.00118	CcSEcCtD
Carbimazole—Pruritus—Etoposide—peripheral nervous system neoplasm	0.000959	0.00116	CcSEcCtD
Carbimazole—Alopecia—Epirubicin—peripheral nervous system neoplasm	0.000945	0.00114	CcSEcCtD
Carbimazole—Rash—Cisplatin—peripheral nervous system neoplasm	0.000933	0.00113	CcSEcCtD
Carbimazole—Dermatitis—Cisplatin—peripheral nervous system neoplasm	0.000932	0.00113	CcSEcCtD
Carbimazole—CYP19A1—Metabolism—PPIP5K2—peripheral nervous system neoplasm	0.000916	0.00525	CbGpPWpGaD
Carbimazole—Angiopathy—Doxorubicin—peripheral nervous system neoplasm	0.000898	0.00109	CcSEcCtD
Carbimazole—TPO—Metabolism—ENO2—peripheral nervous system neoplasm	0.000889	0.0051	CbGpPWpGaD
Carbimazole—Nausea—Cisplatin—peripheral nervous system neoplasm	0.000879	0.00106	CcSEcCtD
Carbimazole—Alopecia—Doxorubicin—peripheral nervous system neoplasm	0.000874	0.00106	CcSEcCtD
Carbimazole—Ill-defined disorder—Epirubicin—peripheral nervous system neoplasm	0.000864	0.00105	CcSEcCtD
Carbimazole—Rash—Etoposide—peripheral nervous system neoplasm	0.000855	0.00104	CcSEcCtD
Carbimazole—Dermatitis—Etoposide—peripheral nervous system neoplasm	0.000854	0.00103	CcSEcCtD
Carbimazole—Headache—Etoposide—peripheral nervous system neoplasm	0.000849	0.00103	CcSEcCtD
Carbimazole—Malaise—Epirubicin—peripheral nervous system neoplasm	0.00084	0.00102	CcSEcCtD
Carbimazole—Leukopenia—Epirubicin—peripheral nervous system neoplasm	0.000833	0.00101	CcSEcCtD
Carbimazole—Nausea—Etoposide—peripheral nervous system neoplasm	0.000805	0.000975	CcSEcCtD
Carbimazole—Ill-defined disorder—Doxorubicin—peripheral nervous system neoplasm	0.000799	0.000968	CcSEcCtD
Carbimazole—Arthralgia—Epirubicin—peripheral nervous system neoplasm	0.000793	0.00096	CcSEcCtD
Carbimazole—Myalgia—Epirubicin—peripheral nervous system neoplasm	0.000793	0.00096	CcSEcCtD
Carbimazole—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—peripheral nervous system neoplasm	0.000787	0.000954	CcSEcCtD
Carbimazole—Discomfort—Epirubicin—peripheral nervous system neoplasm	0.000783	0.000949	CcSEcCtD
Carbimazole—Malaise—Doxorubicin—peripheral nervous system neoplasm	0.000777	0.000941	CcSEcCtD
Carbimazole—Leukopenia—Doxorubicin—peripheral nervous system neoplasm	0.000771	0.000934	CcSEcCtD
Carbimazole—Infection—Epirubicin—peripheral nervous system neoplasm	0.000755	0.000914	CcSEcCtD
Carbimazole—TPO—Metabolism—BCHE—peripheral nervous system neoplasm	0.000751	0.00431	CbGpPWpGaD
Carbimazole—Nervous system disorder—Epirubicin—peripheral nervous system neoplasm	0.000745	0.000903	CcSEcCtD
Carbimazole—Thrombocytopenia—Epirubicin—peripheral nervous system neoplasm	0.000744	0.000901	CcSEcCtD
Carbimazole—Skin disorder—Epirubicin—peripheral nervous system neoplasm	0.000738	0.000894	CcSEcCtD
Carbimazole—Myalgia—Doxorubicin—peripheral nervous system neoplasm	0.000733	0.000888	CcSEcCtD
Carbimazole—Arthralgia—Doxorubicin—peripheral nervous system neoplasm	0.000733	0.000888	CcSEcCtD
Carbimazole—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—peripheral nervous system neoplasm	0.000728	0.000882	CcSEcCtD
Carbimazole—Discomfort—Doxorubicin—peripheral nervous system neoplasm	0.000725	0.000878	CcSEcCtD
Carbimazole—TPO—Metabolism—SLC2A1—peripheral nervous system neoplasm	0.000717	0.00411	CbGpPWpGaD
Carbimazole—TPO—Metabolism—TH—peripheral nervous system neoplasm	0.000706	0.00405	CbGpPWpGaD
Carbimazole—Infection—Doxorubicin—peripheral nervous system neoplasm	0.000698	0.000846	CcSEcCtD
Carbimazole—Musculoskeletal discomfort—Epirubicin—peripheral nervous system neoplasm	0.000692	0.000839	CcSEcCtD
Carbimazole—Nervous system disorder—Doxorubicin—peripheral nervous system neoplasm	0.000689	0.000835	CcSEcCtD
Carbimazole—Thrombocytopenia—Doxorubicin—peripheral nervous system neoplasm	0.000688	0.000834	CcSEcCtD
Carbimazole—Skin disorder—Doxorubicin—peripheral nervous system neoplasm	0.000683	0.000827	CcSEcCtD
Carbimazole—Musculoskeletal discomfort—Doxorubicin—peripheral nervous system neoplasm	0.000641	0.000776	CcSEcCtD
Carbimazole—Feeling abnormal—Epirubicin—peripheral nervous system neoplasm	0.000626	0.000758	CcSEcCtD
Carbimazole—CYP19A1—Metabolism—HSD17B12—peripheral nervous system neoplasm	0.000619	0.00355	CbGpPWpGaD
Carbimazole—Urticaria—Epirubicin—peripheral nervous system neoplasm	0.000604	0.000731	CcSEcCtD
Carbimazole—Body temperature increased—Epirubicin—peripheral nervous system neoplasm	0.000601	0.000728	CcSEcCtD
Carbimazole—Feeling abnormal—Doxorubicin—peripheral nervous system neoplasm	0.000579	0.000702	CcSEcCtD
Carbimazole—TPO—Metabolism—GNAS—peripheral nervous system neoplasm	0.000577	0.0033	CbGpPWpGaD
Carbimazole—CYP19A1—Integrated Breast Cancer Pathway—CASP3—peripheral nervous system neoplasm	0.000569	0.00326	CbGpPWpGaD
Carbimazole—TPO—Metabolism—ABCB1—peripheral nervous system neoplasm	0.000566	0.00324	CbGpPWpGaD
Carbimazole—Hypersensitivity—Epirubicin—peripheral nervous system neoplasm	0.00056	0.000678	CcSEcCtD
Carbimazole—Urticaria—Doxorubicin—peripheral nervous system neoplasm	0.000559	0.000677	CcSEcCtD
Carbimazole—Body temperature increased—Doxorubicin—peripheral nervous system neoplasm	0.000556	0.000673	CcSEcCtD
Carbimazole—Pruritus—Epirubicin—peripheral nervous system neoplasm	0.000538	0.000651	CcSEcCtD
Carbimazole—Hypersensitivity—Doxorubicin—peripheral nervous system neoplasm	0.000518	0.000627	CcSEcCtD
Carbimazole—CYP19A1—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	0.000514	0.00295	CbGpPWpGaD
Carbimazole—Pruritus—Doxorubicin—peripheral nervous system neoplasm	0.000497	0.000603	CcSEcCtD
Carbimazole—Rash—Epirubicin—peripheral nervous system neoplasm	0.000479	0.00058	CcSEcCtD
Carbimazole—Dermatitis—Epirubicin—peripheral nervous system neoplasm	0.000479	0.00058	CcSEcCtD
Carbimazole—Headache—Epirubicin—peripheral nervous system neoplasm	0.000476	0.000577	CcSEcCtD
Carbimazole—Nausea—Epirubicin—peripheral nervous system neoplasm	0.000451	0.000547	CcSEcCtD
Carbimazole—CYP19A1—Metabolism—GNS—peripheral nervous system neoplasm	0.000447	0.00256	CbGpPWpGaD
Carbimazole—CYP19A1—Integrated Breast Cancer Pathway—MYC—peripheral nervous system neoplasm	0.000444	0.00254	CbGpPWpGaD
Carbimazole—Rash—Doxorubicin—peripheral nervous system neoplasm	0.000443	0.000537	CcSEcCtD
Carbimazole—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	0.000443	0.000536	CcSEcCtD
Carbimazole—Headache—Doxorubicin—peripheral nervous system neoplasm	0.00044	0.000534	CcSEcCtD
Carbimazole—CYP19A1—Metabolism—NME1—peripheral nervous system neoplasm	0.000429	0.00246	CbGpPWpGaD
Carbimazole—Nausea—Doxorubicin—peripheral nervous system neoplasm	0.000418	0.000506	CcSEcCtD
Carbimazole—CYP19A1—Metabolism—COX2—peripheral nervous system neoplasm	0.000413	0.00237	CbGpPWpGaD
Carbimazole—CYP19A1—Integrated Breast Cancer Pathway—TP53—peripheral nervous system neoplasm	0.000365	0.00209	CbGpPWpGaD
Carbimazole—CYP19A1—Integrated Breast Cancer Pathway—AKT1—peripheral nervous system neoplasm	0.000308	0.00176	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—ENO2—peripheral nervous system neoplasm	0.000271	0.00155	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—BCHE—peripheral nervous system neoplasm	0.000229	0.00131	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—SLC2A1—peripheral nervous system neoplasm	0.000218	0.00125	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—TH—peripheral nervous system neoplasm	0.000215	0.00123	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—GNAS—peripheral nervous system neoplasm	0.000176	0.00101	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—ABCB1—peripheral nervous system neoplasm	0.000172	0.000988	CbGpPWpGaD
Carbimazole—TPO—Metabolism—AKT1—peripheral nervous system neoplasm	0.000156	0.000892	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—AKT1—peripheral nervous system neoplasm	4.74e-05	0.000272	CbGpPWpGaD
